新聞
新聞
- Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S.
03.03.2022 / 13:30 - GlobeNewswire - Nirsevimab significantly protected infants against RSV disease in Phase 3 trial
03.03.2022 / 08:00 - GlobeNewswire - MATTHEW J. BRUDERMAN HOSTS RECORD SETTING FUNDRAISER FOR NEW YORK REPUBLICAN GUBERNATORIAL CANDIDATE REP. LEE ZELDIN
03.03.2022 / 00:01 - GlobeNewswire - Enthusiast Gaming and Hut 8 Sign Multi-Year Strategic Partnership
02.03.2022 / 13:00 - GlobeNewswire - Snap One to Host Women in Technology Summit to Celebrate International Women’s Day
01.03.2022 / 22:10 - GlobeNewswire - Deveron Announces Closing of Overnight Marketed Public Offering
25.02.2022 / 15:11 - Newsfile Corp - Myovant Sciences Receives Positive CHMP Opinion for ORGOVYX® (relugolix) for the Treatment of Advanced Prostate Cancer
25.02.2022 / 15:00 - GlobeNewswire - New ACM TechBrief Spotlights Privacy, Ethics Problems with Facial Recognition Technology
24.02.2022 / 16:47 - GlobeNewswire - JAMA Publication Highlights VASCEPA® (Icosapent Ethyl) Cardiovascular Risk Reduction Extends to Cost Effectiveness at Patient Level
24.02.2022 / 13:30 - GlobeNewswire - Cerberus Cyber Sentinel Corporation (Nasdaq: CISO) to Ring The Nasdaq Stock Market Opening Bell
23.02.2022 / 13:45 - GlobeNewswire